ArticleFrontiers in endocrinology2026

Tirzepatide and reduced risk of pulmonary embolism and deep vein thrombosis: a multicenter U.S. cohort study.

Fredy Kahkedjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.